Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence

  • Kamal Hamed, Laurie Debonnett
  • Therapeutic Advances in Respiratory Disease, February 2017, SAGE Publications
  • DOI: 10.1177/1753465817691239

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1177/1753465817691239

The following have contributed to this page: Dr Kamal Hamed